Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 1, 2023
Researchers showed the proportion of individuals in the United States diagnosed with advanced-stage colorectal cancer (CRC) increased from 52% in the mid-2000s to 60% in 2019. In addition, diagnoses of people under 55 years of age doubled from 11% (1 in 10) in 1995 to 20% (1 in 5) in 2019.
-
Mar 1, 2023
La Sociedad Americana Contra El Cáncer publica las nuevas estadísticas sobre el cáncer colorrectal; los cambios rápidos hacia enfermedades más avanzadas y las personas más jóvenes
-
Feb 23, 2023American Cancer Society researchers stress the need to improve access to cancer screenings
According to a new, large study led by researchers at the American Cancer Society (ACS), millions of people in the United States continued to miss critical cancer screening tests during the second year of the COVID-19 pandemic.
-
Feb 23, 2023
Continuing their support of increased access to quality care across the cancer continuum, AstraZeneca has committed $2.8 million toward the American Cancer Society’s (ACS) Navigation Capacity-Building Initiative Grant Program.
-
Feb 21, 2023
To address the lack of diversity in research environments, the American Cancer Society (ACS) has announced the creation of the American Cancer Society Center for Diversity in Cancer Research Training.
-
Feb 15, 2023During American Heart Month, the American Cancer Society stresses prevention to help lower the chance of heart disease for people with cancer
American Cancer Society (ACS) research estimates there are more than 18 million adult survivors of cancer in the United States, and that number is expected to climb to more than 22 million by 2030. Although that’s encouraging news, it also puts increasing numbers of survivors at risk for cardiovascular disease or CVD.
-
Feb 2, 2023American Cancer Society and ACS CAN Continue Commitment to End Cancer As We Know It, For Everyone
-
Feb 1, 2023Program to support and fund scientific founders and their early-stage companies among American Cancer Society-affiliated postdoctoral and early career researchers